Industry News
Pharmaceutical Industry News
Apellis, nearing FDA filing for its eye drug, starts early awareness push
Apellis, nearing FDA filing for its eye drug, starts early awareness push badams Fri, 04/22/2022 - 03:56
‘Betrayal of public trust’: Pfizer under fire for resisting Paxlovid compulsory license
'Betrayal of public trust': Pfizer under fire for resisting Paxlovid compulsory license zbecker Thu, 04/21/2022 - 14:40
Fast-growing Catalent plots $350M expansion and 1,000 new hires in US
Fast-growing Catalent plots $350M expansion and 1,000 new hires in US fkansteiner Thu, 04/21/2022 - 13:08
COVID-19 vaccine sales slumping now, but analysts optimistic about rebound later this year
COVID-19 vaccine sales slumping now, but analysts optimistic about rebound later this year kdunleavy Thu, 04/21/2022 - 12:01
In Repatha patent feud, Supreme Court asks United States’ top lawyer to weigh Amgen’s appeal
In Repatha patent feud, Supreme Court asks United States' top lawyer to weigh Amgen's appeal fkansteiner Thu, 04/21/2022 - 10:14
Biogen brings an unlikely lobbyist into its Alzheimer’s corner. Could a CMS challenge follow?
Biogen brings an unlikely lobbyist into its Alzheimer's corner. Could a CMS challenge follow? aliu Thu, 04/21/2022 - 10:12
Sanofi’s latest analysis of Rezurock can inform future research, company says
Sanofi's latest analysis of Rezurock can inform future research, company says kdunleavy Thu, 04/21/2022 - 09:10
Enzyvant to build regenerative medicine manufacturing plant in North Carolina
Enzyvant to build regenerative medicine manufacturing plant in North Carolina jkeenan Thu, 04/21/2022 - 08:55
AstraZeneca’s Evusheld offers at least 6 months of COVID protection in high-risk patients, study finds
AstraZeneca's Evusheld offers at least 6 months of COVID protection in high-risk patients, study finds fkansteiner Thu, 04/21/2022 - 08:33
Eli Lilly takes to social media for a personal touch to its Alzheimer’s campaign
Eli Lilly takes to social media for a personal touch to its Alzheimer’s campaign badams Thu, 04/21/2022 - 04:40
J&J, Endo and McKesson settle Alabama opioid litigation for $276M
J&J, Endo and McKesson settle Alabama opioid litigation for $276M zbecker Wed, 04/20/2022 - 13:33
Sanofi tees off work on €400M ‘factory of the future’ in Singapore
Sanofi tees off work on €400M 'factory of the future' in Singapore fkansteiner Wed, 04/20/2022 - 13:25
Ohio Doctor Is Acquitted of Killing Patients With Fentanyl
The doctor, William Husel, had faced 14 counts of murder after his patients overdosed on fentanyl, the powerful opioid.
GlaxoSmithKline manufacturing staffers in UK vote to strike over ‘derisory’ pay raise offer
GlaxoSmithKline manufacturing staffers in UK vote to strike over 'derisory' pay raise offer fkansteiner Wed, 04/20/2022 - 11:04
Seagen plots new biologics plant to amp up antibody drug production
Seagen plots new biologics plant to amp up antibody drug production aliu Wed, 04/20/2022 - 11:02
FDA swats back Teva, MedinCell’s long-acting schizophrenia drug application
FDA swats back Teva, MedinCell's long-acting schizophrenia drug application kdunleavy Wed, 04/20/2022 - 11:00
Merck vet Romanelli returns as international human health chief after brief stint as CEO at Chinese drugmaker
Merck vet Romanelli returns as international human health chief after brief stint as CEO at Chinese drugmaker kdunleavy Wed, 04/20/2022 - 09:15
AbbVie joins roster of Big Pharmas donating Russian profits as war in Ukraine rages on
AbbVie joins roster of Big Pharmas donating Russian profits as war in Ukraine rages on fkansteiner Wed, 04/20/2022 - 08:39
Merck Foundation ditches ads for its first TV program as it tackles health, social issues in Africa
Merck Foundation ditches ads for its first TV program as it tackles health, social issues in Africa badams Wed, 04/20/2022 - 08:32
As safety signals mount, FDA aims to crack down on PI3K blood cancer nods
As safety signals mount, FDA aims to crack down on PI3K blood cancer nods aliu Wed, 04/20/2022 - 07:56